These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6772184)

  • 21. Bioassay of leukotrienes.
    Dahlén SE; Björck T; Hedqvist P
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():615-21. PubMed ID: 2823561
    [No Abstract]   [Full Text] [Related]  

  • 22. Novel leukotriene antagonists: structure activity of analogs of LTD4. Replacement of the 1-carboxylic group by a methyl group ("methyl principle") results in leukotriene antagonists and phospholipase inhibitors.
    von Sprecher A; Ernest I; Main A; Beck A; Breitenstein W; Märki F; Bray MA
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():519-25. PubMed ID: 2959107
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of slow reacting substance as a family of thiolipids derived from arachidonic acid.
    Parker CW; Jakschik BA; Huber MG; Falkenhein SF
    Biochem Biophys Res Commun; 1979 Aug; 89(4):1186-92. PubMed ID: 496949
    [No Abstract]   [Full Text] [Related]  

  • 24. Generation of leukotrienes by purified human lung mast cells.
    MacGlashan DW; Schleimer RP; Peters SP; Schulman ES; Adams GK; Newball HH; Lichtenstein LM
    J Clin Invest; 1982 Oct; 70(4):747-51. PubMed ID: 7119113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel leukotriene formed by transpeptidation of leukotriene E.
    Bernström K; Hammarström S
    Biochem Biophys Res Commun; 1982 Dec; 109(3):800-4. PubMed ID: 6130764
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative biological activity of natural and synthetic leukotrienes.
    Baker SR; Boot JR; Dawson W; Jamieson WB; Osborne DJ; Sweatman WJ
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():223-7. PubMed ID: 6283843
    [No Abstract]   [Full Text] [Related]  

  • 27. Lipoxygenase pathways.
    Taylor GW; Morris HR
    Br Med Bull; 1983 Jul; 39(3):219-22. PubMed ID: 6313113
    [No Abstract]   [Full Text] [Related]  

  • 28. Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources.
    Lewis RA; Austen KF; Drazen JM; Clark DA; Marfat A; Corey EJ
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3710-4. PubMed ID: 6106193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slow-reacting substance of anaphylaxis: purification and characterisation.
    Morris HR; Taylor GW; Piper PJ; Sirois P; Tippins JR
    FEBS Lett; 1978 Mar; 87(2):203-6. PubMed ID: 631337
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of leukotrienes in the sputum of patients with cystic fibrosis.
    Cromwell O; Walport MJ; Taylor GW; Morris HR; O'Driscoll BR; Kay AB
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():251-7. PubMed ID: 6283844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse peritoneal macrophages release leukotriene C in response to a phagocytic stimulus.
    Rouzer CA; Scott WA; Cohn ZA; Blackburn P; Manning JM
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4928-32. PubMed ID: 6933538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conversion of 14C-labeled eicosapentaenoic acid (n-3) to leukotriene C5.
    Hammarström S
    Biochim Biophys Acta; 1981 Feb; 663(2):575-7. PubMed ID: 6111355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Slow reacting substance of anaphylaxis, SRS-A; assignment of the stereochemistry.
    Morris HR; Taylor GW; Rokach J; Girard Y; Piper PJ; Tippins JR; Samhoun MN
    Prostaglandins; 1980 Sep; 20(3):601-7. PubMed ID: 7422903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukotriene generation by eosinophils.
    Jörg A; Henderson WR; Murphy RC; Klebanoff SJ
    J Exp Med; 1982 Feb; 155(2):390-402. PubMed ID: 6120203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effects of oxatomide on several activities of SRS-A and synthetic leukotrienes in guinea-pigs and rats.
    Ohmori K; Ishii H; Kubota T; Shuto K; Nakamizo N
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):139-50. PubMed ID: 2862849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and some physicochemical properties of slow-reacting substance of anaphylaxis (SRS-A) from sensitized guinea pig lung.
    Watanabe S; Koda A
    Microbiol Immunol; 1979; 23(10):1009-22. PubMed ID: 42007
    [No Abstract]   [Full Text] [Related]  

  • 37. Release of slow reacting substance from rabbit ocular tissues.
    Kin K
    Jpn J Ophthalmol; 1984; 28(3):263-73. PubMed ID: 6151994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid and simple methods for the investigation of lipoxygenase pathways in human granulocytes.
    Veenstra J; van de Pol H; van der Torre H; Schaafsma G; Ockhuizen T
    J Chromatogr; 1988 Oct; 431(2):413-7. PubMed ID: 2854132
    [No Abstract]   [Full Text] [Related]  

  • 39. Bioconversion of C-6 sulfidopeptide leukotrienes by the responding guinea pig ileum determines the time course of its contraction.
    Krilis S; Lewis RA; Corey EJ; Austen KF
    J Clin Invest; 1983 Apr; 71(4):909-15. PubMed ID: 6300193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of 5-lipoxygenase products in the lung.
    Murphy RC
    Prog Biochem Pharmacol; 1985; 20():84-100. PubMed ID: 2986158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.